Boston Scientific

This article may rely excessively on sources too closely associated with the subject, potentially preventing the article from being verifiable and neutral. Please help improve it by replacing them with more appropriate citations to reliable, independent, third-party sources. (December 2018) (Learn how and when to remove this message)

This article contains promotional content. Please help improve it by removing promotional language and inappropriate external links, and by adding encyclopedic text written from a neutral point of view. (July 2024) (Learn how and when to remove this message)

Boston Scientific Corporation

Company type	Public
Traded as	NYSE: BSX S&P 500 component
ISIN	US1011371077
Industry	Medical device
Founded	June 29, 1979; 45 years ago (1979-06-29) in Watertown, Massachusetts
Founders	John Abele Peter Nicholas
Headquarters	Marlborough, Massachusetts, U.S.
Key people	Michael F. Mahoney (Chairman and CEO) Daniel Brennan (CFO)
Revenue	US$14.24 billion (2023)[1]
Operating income	US$2.343 billion (2023)[1]
Net income	US$1.592 billion (2023)[1]
Total assets	US$35.14 billion (2023)[1]
Total equity	US$19.28 billion (2023)[1]
Number of employees	c. 48,000[1] (2023)
Website	bostonscientific.com

42°21′37.3″N 71°33′32.6″W / 42.360361°N 71.559056°W / 42.360361; -71.559056 Boston Scientific Corporation (BSC), headquartered in Marlborough, Massachusetts and incorporated in Delaware,^[2] is a biomedical/biotechnology engineering firm and multinational manufacturer of medical devices used in interventional medical specialties, including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology, cardiac surgery, vascular surgery, endoscopy, oncology, urology and gynecology. Boston Scientific is widely known for the development of the Taxus Stent, a drug-eluting stent which is used to open clogged arteries.^[3] With the full acquisition of Cameron Health in June 2012, the company also became notable for offering a minimally invasive implantable cardioverter-defibrillator (ICD) which they call the EMBLEM subcutaneous implantable defibrillator (S-ICD).^[4][5]